Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

epirubicinol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
PurposeMost adjuvant breast cancer treatment regimens include the combination of an anthracycline (epirubicin or doxorubicin) and… Expand
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2007
2007
The antitumor anthracycline doxorubicin induces a dose-related cardiotoxicity that correlates with the myocardial levels of its… Expand
Is this relevant?
2004
2004
SummaryThe pharmacokinetics and metabolism of doxorubicin (DX) and epirubicin (epiDX) were investigated in eight cancer patients… Expand
  • table 1
Is this relevant?
2003
2003
We present a high-performance liquid chromatography (HPLC) method suitable for the analysis of epirubicin and its metabolite… Expand
Is this relevant?
1999
1999
PURPOSE To investigate whether paclitaxel and docetaxel influence the pharmacokinetics and metabolism of epirubicin. PATIENTS… Expand
Is this relevant?
1997
1997
PURPOSE To determine the maximum-tolerated dose (MTD) of paclitaxel over 3 hours with a fixed dose of epirubicin, to investigate… Expand
Is this relevant?
1991
1991
SummaryDetailed pharmacokinetic analysis and subsequent evaluation of myelotoxicity were performed in 55 patients who had been… Expand
  • figure 1
  • table 1
  • table 2
  • figure 4
  • figure 2
Is this relevant?
1989
1989
We have studied the growth inhibition, DNA synthesis inhibition and cell incorporation of five 13-dihydrometabolites of… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Pharmacokinetics of doxorubicin (DOX), epidoxorubicin (EPI), and their metabolites in plasma have been performed in eight… Expand
Is this relevant?
1985
1985
We have studied the metabolism and pharmacokinetics of epirubicin (4'-epidoxorubicin), as compared to those of doxorubicin, in a… Expand
Is this relevant?